Stay updated on Glycine Supplement for Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.

Latest updates to the Glycine Supplement for Severe COVID-19 Clinical Trial page
- Check8 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, indicating a new version of the content.SummaryDifference0.0%

- Check15 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, signaling a newer release of the page content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRecruitment is now marked as closed for this study, and new help/navigation sections were added while an old Intervention / Treatment heading formatting was removed, reflecting UI/structure updates rather than changes to the study data.SummaryDifference0.5%

- Check36 days agoChange DetectedThe page now shows revision v3.5.5, signaling a small update to the page's metadata or formatting rather than changes to the trial details.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now shows revision v3.5.4, replacing the previous v3.5.3. This reflects a minor update to the site's revision labeling in the page metadata.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page’s software/display revision label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Glycine Supplement for Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glycine Supplement for Severe COVID-19 Clinical Trial page.